Keyvan Heydari

2.4k total citations · 1 hit paper
34 papers, 550 citations indexed

About

Keyvan Heydari is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Keyvan Heydari has authored 34 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Keyvan Heydari's work include COVID-19 Clinical Research Studies (9 papers), Long-Term Effects of COVID-19 (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Keyvan Heydari is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), Long-Term Effects of COVID-19 (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Keyvan Heydari collaborates with scholars based in Iran, United States and Singapore. Keyvan Heydari's co-authors include Reza Alizadeh‐Navaei, Amir Shamshirian, Mohammad Yousefi, Sulmaz Ghahramani, Saeed Shahabi, Kamran Bagheri Lankarani, Danial Shamshirian, Mahmood Moosazadeh, Akbar Hedayatizadeh‐Omran and Layla Shojaie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and BMC Cancer.

In The Last Decade

Keyvan Heydari

33 papers receiving 539 citations

Hit Papers

A Systematic Review and Meta-Analysis of Burnout Among He... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keyvan Heydari Iran 10 148 147 144 110 88 34 550
Maeve S. McNamara United States 1 80 0.5× 321 2.2× 119 0.8× 105 1.0× 174 2.0× 2 683
Carmen Cecilia Laborde-Cárdenas Colombia 7 48 0.3× 59 0.4× 145 1.0× 23 0.2× 37 0.4× 12 568
Andreas S. Triantafyllis Greece 13 106 0.7× 30 0.2× 201 1.4× 53 0.5× 55 0.6× 53 719
Mikako Obika Japan 10 92 0.6× 49 0.3× 98 0.7× 38 0.3× 97 1.1× 54 663
Irene Sequí‐Domínguez Spain 11 105 0.7× 125 0.9× 32 0.2× 67 0.6× 70 0.8× 40 609
Janine Alessi Brazil 8 57 0.4× 63 0.4× 93 0.6× 35 0.3× 43 0.5× 24 334
Drew Payne United Kingdom 13 51 0.3× 52 0.4× 37 0.3× 52 0.5× 21 0.2× 72 643
Sarah Cox United Kingdom 10 45 0.3× 58 0.4× 46 0.3× 133 1.2× 113 1.3× 20 670
Francky Teddy Endomba France 12 22 0.1× 215 1.5× 44 0.3× 48 0.4× 89 1.0× 44 576
Brian Vastag United States 15 94 0.6× 70 0.5× 70 0.5× 51 0.5× 23 0.3× 163 775

Countries citing papers authored by Keyvan Heydari

Since Specialization
Citations

This map shows the geographic impact of Keyvan Heydari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyvan Heydari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyvan Heydari more than expected).

Fields of papers citing papers by Keyvan Heydari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyvan Heydari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyvan Heydari. The network helps show where Keyvan Heydari may publish in the future.

Co-authorship network of co-authors of Keyvan Heydari

This figure shows the co-authorship network connecting the top 25 collaborators of Keyvan Heydari. A scholar is included among the top collaborators of Keyvan Heydari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyvan Heydari. Keyvan Heydari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akha, Ozra, et al.. (2024). Subacute thyroiditis after SARS‐CoV‐2 vaccination: A case report. SHILAP Revista de lepidopterología. 12(4). e8678–e8678.
2.
Ghasemian, Roya, et al.. (2023). Renal aspergillosis after COVID‐19‐associated pulmonary aspergillosis: A case report. SHILAP Revista de lepidopterología. 11(9). e7882–e7882. 2 indexed citations
3.
Heydari, Keyvan, et al.. (2022). LGR5 As a Potential Therapeutic Target for Breast Cancer: A SystematicReview and Meta-analysis. Current Stem Cell Research & Therapy. 18(5). 690–698. 2 indexed citations
4.
Heydari, Keyvan, Mohammad Yousefi, Reza Alizadeh‐Navaei, et al.. (2022). Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. The Turkish Journal of Gastroenterology. 33(3). 171–181. 18 indexed citations
5.
Alizadeh‐Navaei, Reza, et al.. (2021). Diagnostic Value of Intraoperative Frozen Section in Breast-Conserving Surgery: A Systematic Review and Meta-analysis. International Journal of Cancer Management. 14(11). 2 indexed citations
6.
Zeydi, Amir Emami, et al.. (2021). The Attitude of Iranian Critical Care Nurses Toward Euthanasia. Critical Care Nursing Quarterly. 45(1). 62–73. 6 indexed citations
7.
Mousavi, Seyed Abbas, Keyvan Heydari, Majid Saeedi, et al.. (2021). Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial. Journal of Medical Virology. 94(1). 263–271. 53 indexed citations
8.
Alizadeh‐Navaei, Reza, Fatemeh Espahbodi, Hamed Jafarpour, et al.. (2021). Epidemiology of Cytomegalovirus among Patients Undergoing Hemodialysis in Sari, Iran 2017-2018. SHILAP Revista de lepidopterología. 31(199). 179–185. 2 indexed citations
9.
Hedayatizadeh‐Omran, Akbar, et al.. (2021). Serum vitamin d concentrations in covid19 patients. SHILAP Revista de lepidopterología. 31(195). 30–36. 1 indexed citations
10.
11.
Zarghami, Mehran, et al.. (2020). Validity of self‐reporting depression in the Tabari cohort study population. Neuropsychopharmacology Reports. 40(4). 342–347. 5 indexed citations
12.
13.
Heydari, Keyvan, Amir Shamshirian, & Reza Alizadeh‐Navaei. (2020). Reply to: “The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis”. Clinical & Translational Oncology. 22(10). 1908–1908. 5 indexed citations
15.
Malekan, Mohammad, et al.. (2020). Liver Function in Novel Coronavirus Disease (COVID-19): A Systematic Review and Meta-Analysis. medRxiv. 3 indexed citations
16.
Heydari, Keyvan, et al.. (2020). The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis. Clinical & Translational Oncology. 22(10). 1825–1837. 12 indexed citations
17.
Ghasemian, Roya, et al.. (2020). High-resolution computed tomography finding in 552 patients with symptomatic COVID-19: first report from north of Iran. Emergency Radiology. 27(6). 633–639. 11 indexed citations
18.
Shamshirian, Amir, Keyvan Heydari, Amir Reza Aref, et al.. (2020). Breast cancer risk factors in Iran: a systematic review & meta-analysis. Hormone Molecular Biology and Clinical Investigation. 41(4). 34 indexed citations
19.
Shamshirian, Amir, Amir Reza Aref, George W. Yip, et al.. (2020). Diagnostic Value of Serum HER2 Levels in Breast Cancer: A Systematic Review and Meta-Analysis. Research Square. 1 indexed citations
20.
Heydari, Keyvan, et al.. (2008). DENTAL STUDENTS' COMPETENCIES IN COMMUNITY DENTISTRY COURSE. Iranian Journal of Medical Education. 7(218). 201–208. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026